A Phase 1 interventional study of Salvinorin A in Healthy, sponsored by Johns Hopkins University. Completed at 2 sites in United States. Open to participants aged 21 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-03-24.
Sponsored by Johns Hopkins University · Phase 1, Interventional, and Basic science
This study is characterizing the subject-rated and behavioral effects of salvinorin A in healthy volunteers. The investigators hypothesize the salvinorin A will have hallucinogen-like effects.
404 studies on the registry are indexed under Behavior; 167 are open to participants now.
This study's planned enrollment of 14 is below the median of 120 across 316 interventional studies indexed under Behavior.
Browse Behavior studies →Johns Hopkins University is the lead sponsor of 1,809 studies on the registry; 314 are open to participants now.
Of its 208 completed or terminated interventional studies of FDA-regulated products, 144 (69%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
General Medical Exclusion Criteria
Psychiatric Exclusion Criteria
Drug: Salvinorin A
This is an initial dose ranging study
Hallucinogen Rating Scale
Time frame: Approximately 1 hour after drug administration
The record gives a start of Nov 2008 and a primary completion of Nov 2013. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Salvinorin A